Interpretable Artificial Intelligence in Assisting Treatment Response Prediction for Locally Advanced Rectal Cancer After Neoadjuvant Chemoradiotherapy: A Prospective, Multicenter, Human-Model Interaction Study [0.03%]
基于新辅助放化疗的局部晚期直肠癌个体化治疗反应预测的人工智能模型及其可解释性：一项前瞻性多中心研究
Xiaolin Pang,Xiaobo Chen,Guangdong Zeng et al.
Xiaolin Pang et al.
Purpose: Preoperative assessment of pathologic complete response (pCR) to neoadjuvant therapy is an urgent need for anorectal preservation in patients with locally advanced rectal cancer (LARC). Artificial intelligence as...
Misinformation and Overestimation of Computed Tomography Lung Cancer Screening Harms-Methodology Matters: A Joint Statement from The Society of Thoracic Surgeons, the American Society for Radiation Oncology, and the American College of Radiology [0.03%]
关于胸部手术医师学会、美国放射肿瘤学会和美国放射学院对计算机断层扫描肺癌筛查危害的误传和过度估计——方法学问题重要性联合声明
Haley I Tupper,Joseph B Shrager,Drew Moghanaki et al.
Haley I Tupper et al.
The Critical Role of Dose Homogeneity in Modern Breast Hypofractionation [0.03%]
现代乳腺低分割放射治疗中剂量均匀性的作用不容忽视
Fady Sourial,Colin Champ,Sushil Beriwal
Fady Sourial
The evolution of breast cancer radiotherapy has witnessed a paradigm shift from conventional fractionation to hypofractionation and now ultra-hypofractionation, with multiple randomized trials demonstrating non-inferiority in both disease c...
Consolidation Chemotherapy after Preoperative Chemoradiotherapy for Locally Advanced Rectal Cancer: 7-Year Follow-Up Results of a Randomized Multicenter Trial (KCSG CO 14-03) [0.03%]
术前放化疗后晚期直肠癌患者辅助强化化疗：KCSG CO 14-03 随机多中心试验的七年随访结果
Sojin Kim,Moon Ki Choi,Dae Yong Kim et al.
Sojin Kim et al.
Purpose: Total neoadjuvant therapy (TNT) has become the standard treatment for locally advanced rectal cancer (LARC). However, the optimal sequence and duration of treatment remain unclear. Hence, the long-term follow-up ...
Proton radiotherapy offers immune-sparing benefits in glioblastoma treatment Proton therapy reduced radiation-induced lymphopenia [0.03%]
质子放射治疗对胶质母细胞瘤的免疫保护作用质子治疗可减少辐射诱导的淋巴细胞减少症
J Coupey,T N Pham,J Toutain et al.
J Coupey et al.
Purpose: Glioblastoma (GB) and x-ray-based radiotherapy are associated with lymphopenia, which worsens prognosis and impairs anti-tumor immunity. Proton therapy, with its dosimetric properties that spare healthy brain tis...
Health Related Quality of Life after SBRT for Oligoprogressive Disease: Results from a Phase II Prospective Trial [0.03%]
立体定向放射治疗寡进展性疾病的生存质量研究：一项二期临床试验的结果分析
Joelle Helou,Rachel Glicksman,Andrea Bezjak et al.
Joelle Helou et al.
Purpose: To report changes in patient-reported health-related quality of life (HRQoL) from a phase II trial evaluating stereotactic body radiotherapy (SBRT) for oligoprogressive (OP) tumors. The study hypothesis was that ...
Erratum to Xiao Y, Benedict S, Cui Y, Glide-Hurst C, Graves S, Jia X, KryF S, Li H, Lin L, Matuszak M, Newpower M, Paganetti H, Qi XS, Roncali E, Rong Y, Sgouros G, Simone 2nd CB, Sunderland JJ, Taylor PA, Tchelebi L, Weldon M, Zou JW, Wuthrick EJ, Machtay M, Le QT, Buchsbaum JC. Embracing the future of clinical trials in radiation therapy: an NRG oncol [0.03%]
饶雪 et al.：拥抱放射治疗临床试验的未来：NRG 肿瘤学和 ASTRO 放射治疗临床试验工作组的建议致信的勘误表
Ying Xiao,Stanley Benedict,Yunfeng Cui et al.
Ying Xiao et al.
In Reply to Wada and Mori [0.03%]
回应和田、森的意见
Yang Xu,Shaun K Loewen
Yang Xu
In Regard to Xu et al [0.03%]
关于徐等人撰写的论文
Yuki Wada,Naoko Mori
Yuki Wada
In Reply to Cella [0.03%]
答塞拉女士书
Drew Moghanaki,Sue S Yom,Neha Vapiwala
Drew Moghanaki